Mapping of rehabilitation interventions and assessment methods for patients with liver cirrhosis: a scoping review
- PMID: 40269747
- PMCID: PMC12020051
- DOI: 10.1186/s12876-025-03881-4
Mapping of rehabilitation interventions and assessment methods for patients with liver cirrhosis: a scoping review
Abstract
Background: This scoping review aimed to delineate the detailed components of exercise therapy and the evaluation methods used for patients with liver cirrhosis.
Methods: The methodology involved searching the original PubMed, Web of Science, and Scopus for studies published between January 1975 and March 2025. The search was completed on 13 March 2025. Studies describing exercise therapy for liver cirrhosis patients were selected. Relevant information matching the study objectives, such as intervention duration, content, intensity setting, evaluation criteria, and outcomes, was extracted and documented.
Results: Of the 2314 articles identified, 18 fit the inclusion and exclusion criteria, with a total of 950 participants. The most prevalent form of exercise therapy was a combined aerobic exercise and strength training program (55.6%). Commonly used assessment criteria included the 6-minute walking distance for endurance evaluation (44.4%) and the Chronic Liver Disease Questionnaire for quality of life assessment (33.3%). Intervention durations ranged from 30 to 60 min per day, 2 to 7 days per week, and 8 to 12 weeks. Concerning intensity setting, subjective fatigue levels and heart rate were frequently used (38.9%), though detailed descriptions were limited.
Conclusions: For the establishment of effective exercise therapy for patients with liver cirrhosis, future research should concentrate on tailoring intensity settings according to individual patient needs. Additionally, standardized reporting of intervention details and assessment methods is crucial for improving the quality and comparability of studies in this field.
Keywords: Exercise therapy; FITT; Patients with liver cirrhosis; Scoping review.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: TK received lecture fees from ASKA Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Kowa Company, Ltd., AbbVie GK., Eisai Co., Ltd., Novo Nordisk Pharma Ltd., Janssen Pharmaceutical K.K., Otsuka Pharmaceutical Co., Ltd., EA Pharma Co., Ltd. ST received lecture fees from Otsuka, Abbvie, Asuka, Daiichi Sankyo, Chiome Bioscience, Takeda, Jansen, and Gilead. He also received research grants from Rho to, Asuka, Mochida, Fuji, Stemrim, Abotto, Tsumura, Kiowa, Toso, Touwa, Shionogi, Nihonseibutsu, and scholarship grants from Otsuka, Nihonkayaku, Abbvie, Dainipponsumito, Asahikasei, Pharma, Takeda. The companies have no relationship with this study. The other authors declare that they have no conflict of interest.
Similar articles
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Behavioural interventions for type 2 diabetes: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1. Ont Health Technol Assess Ser. 2009. PMID: 23074526 Free PMC article.
-
Physical exercise for people with cirrhosis.Cochrane Database Syst Rev. 2018 Dec 21;12(12):CD012678. doi: 10.1002/14651858.CD012678.pub2. Cochrane Database Syst Rev. 2018. PMID: 30575956 Free PMC article.
-
The effectiveness of exercise prehabilitation on aerobic capacity, muscle strength and body composition in patients with cirrhosis awaiting liver transplantation: a systematic review and meta-analysis protocol.Syst Rev. 2024 Sep 3;13(1):225. doi: 10.1186/s13643-024-02608-y. Syst Rev. 2024. PMID: 39227981 Free PMC article.
-
Exercise for improving outcomes after osteoporotic vertebral fracture.Cochrane Database Syst Rev. 2019 Jul 5;7(7):CD008618. doi: 10.1002/14651858.CD008618.pub3. Cochrane Database Syst Rev. 2019. PMID: 31273764 Free PMC article.
References
-
- D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31. - PubMed
-
- Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17(6):445–50. - PubMed
-
- Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, Esfandiari N, Baracos V, Montano-Loza AJ, Myers RP. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18(10):1209–16. - PubMed
-
- Merli M, Giusto M, Gentili F, Novelli G, Ferretti G, Riggio O, Corradini SG, Siciliano M, Farcomeni A, Attili AF, et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010;30(2):208–14. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical